Humpa, Ian Carl T.

HRN: 12-68-45  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/27/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/27/2023
09/03/2023
IV
400mg
Q8hours
Empiric
Waiting Final Action 

Indication:  Empiric    Type of Infection:  BloodstreamIntra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: